scholarly journals The Distribution of Human Papillomavirus Type 30 (HPV30) Lineages Among Women With Normal Cervical Cytology in China

2021 ◽  
Author(s):  
Ying LI ◽  
Yifan Guo ◽  
Zhan Wang ◽  
Hui Wang ◽  
Jiao Wang ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Infection Rate ◽  
Dna Sequences ◽  
Normal Cytology ◽  
Hiv Positive Women ◽  
Immunodeficiency Virus ◽  
Normal Cervical Cytology ◽  
Polymerase Chain ◽  
Cervical Diseases ◽  
Lineage Distribution

Abstract Background: Human papillomavirus type 30 (HPV30) is involved in cervical diseases. In human immunodeficiency virus (HIV) positive women, the prevalence HPV30 is almost the same as HPV16. However, HPV30 has seldom been investigated. In order to better understand the prevalence and intratype lineage distribution of HPV30 in China, HPV30 infection among women with normal cytology was investigated.Methods: Prevalence of HPV30 was investigated by the screening of type specific polymerase chain reaction (PCR); intratype lineage distribution was performed by the phylogenetic analysis of the L2 DNA sequences of HPV30 isolates; the diversity of genetic variants of HPV30 isolates was also evaluated. Results: (1) The infection rate of HPV30 was 0.56% (9/1600). (2) All the nine HPV30 isolates belonged to lineage A, none belonged to lineage B. (3) Compared with the HPV30 prototype reference, 87 variations including 79 substitutions, four insertions and four deletions were observed in this study. (4) Sample 4 contained a C base deletion of the E2 gene resulting in an amino acid sequence shift. (5) Sample had a truncated L2 protein.Conclusions: The infection rate of HPV30 is 0.56% in this study. All of the HPV30 isolates belongs to lineage A. Natural L2 and E2 defective isolates of HPV30 were found.

scholarly journals Identification of Genetic Variants of Human Papillomavirus in a Group of Mexican HIV/AIDS Patients and Their Possible Association with Cervical Cancer

2021 ◽  
Vol 70 (4) ◽  
pp. 501-509
Author(s):  
FELIPE ORTIZ-GUTIÉRREZ ◽  
LILIA SÁNCHEZ-MINUTTI ◽  
JOSÉ F. MARTÍNEZ-HERRERA ◽  
INDIANA D. TORRES-ESCOBAR ◽  
ELIAS B. PEZZAT-SAID ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Genetic Variants ◽  
Direct Relationship ◽  
Low Risk ◽  
Hiv Positive ◽  
Hiv Positive Women ◽  
Immunodeficiency Virus ◽  
Regional Population ◽  
Polymerase Chain

Infections caused by the human immunodeficiency virus (HIV) and human papillomavirus (HPV) cause thousands of deaths worldwide each year. So far, there has been no consensus on whether there is a direct relationship between the incidence of neoplasms and the immunosuppression caused by HIV that could help understand if coinfection increases the likelihood of cervical cancer. The objective of the study was to identify the presence of genetic variants of HPV in a group of HIV-positive women and their possible association with cervical cancer. Cervical samples were taken from HIV-positive patients for cytological analysis to identify the HPV genotype by polymerase chain reaction (PCR) and sequencing. The most preva¬lent L1 capsid protein mutations in the HPV genotype were ana¬lyzed in silico. Various types of HPV were identified, both high-risk (HR) and low-risk (LR). The most prevalent genotype was HPV51. Analysis of the L1 gene sequences of HPV51 isolates showed nucleo¬tide variations. Of the samples analyzed in Puebla, Mexico, HPV51 had the highest incidence (17.5%, 7/40). Different mutations, which could be used as population markers, were detected in this area, and they have not been reported in the L1 databases for HPV51 in Mexico. Genotypes 6, 14, 86, 87, 89, and 91, not detected or reported in samples from patients with HPV in Mexico, were also identified. Data from the population analyzed suggest no direct relationship between HIV immunosuppression and cervical cancer, regardless of the high- or low-risk HPV genotype. Furthermore, it is possible to develop regional population markers for the detection of HPV based on the mutations that occur in the sequence of nucleotides analyzed.

A comparative profile of the prevalence and age distribution of human papillomavirus type 16/18 infections among three states of India with focus on northeast India

2007 ◽  
Vol 17 (1) ◽  
pp. 107-117 ◽  
Author(s):  
P. Laikangbam ◽  
S. Sengupta ◽  
P. Bhattacharya ◽  
C. Duttagupta ◽  
Th. Dhabali Singh ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
West Bengal ◽  
Age Distribution ◽  
Age Groups ◽  
Northeast India ◽  
Cervical Lesions ◽  
Hpv Dna ◽  
Human Papillomavirus Type 16 ◽  
Normal Cervical Cytology ◽  
Polymerase Chain

Human papillomavirus (HPV) DNA in cervical scrape samples of married women from Manipur (n= 692) and Sikkim (n= 415) in northeast India was determined and compared with that of women from West Bengal (n= 1112) in eastern India by polymerase chain reaction. HPV prevalence was lower in Manipur (7.4%) than in Sikkim (12.5%), which was closely followed by West Bengal (12.9%). HPV18 was predominant in Manipur (2.03%) and strikingly lower (0.2%) in Sikkim and West Bengal (0.9%), while the reverse was true for HPV16. The proportion of HPV16/18 infections in Manipur (3.3%, 22/672) and Sikkim (3.89%, 14/359) were comparable and significantly lower compared to that in West Bengal (7.8%, 79/1007) among women having normal cervical cytology. Such prevalence was similar among all age groups in Manipur: increased with age for women in Sikkim and dropped with age for those in West Bengal similar to that reported previously. At age ≤30 years, HPV16/18 prevalence in Manipur (3.3%) and Sikkim (2.5%) was comparable but was significantly lower (P < 0.05) in contrast to that in West Bengal (8.8%). Among abnormal cytologic lesions, HPV16/18 infections were significantly higher than in normals (P= 0.000) both in Sikkim (14.3%) and West Bengal (20.9%) and absent in Manipur. Such prevalence was noted among women in Sikkim aged >30 years and equally among those in West Bengal aged ≤30 or >30 years. Thus, women from northeast India, particularly from Manipur, appear less susceptible to HPV16/18 infection and related cervical lesions compared to those from West Bengal, where such proneness was prominently evident at age ≤30 years.

Age factor and implication of human papillomavirus type-specific prevalence in women with normal cervical cytology

2011 ◽  
Vol 140 (3) ◽  
pp. 466-473 ◽  
Author(s):  
C. H. LAI ◽  
A. CHAO ◽  
C. J. CHANG ◽  
C. C. HUANG ◽  
L. C. WANG ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Hormone Replacement ◽  
Menopausal Status ◽  
Hpv Infection ◽  
Population Based ◽  
Cervical Cytology ◽  
Genotype Distribution ◽  
Abnormal Cytology ◽  
Normal Cytology ◽  
Normal Cervical Cytology

SUMMARYThe prevalence and genotype distribution of human papillomavirus (HPV) infection in women with normal cervical cytology varies widely according to the population studied. Two non-overlapping population-based cohort studies of women aged ⩾30 years for the periods 2008–2009 (n=5026) and 2004–2005 (n=10 014) were analysed. The prevalence rate of HPV was 11·0% (95% CI 10·5–11·6). HPV infection was significantly associated with age, menopausal status, and inversely associated with hormone replacement therapy. There was an increasing trend of α3/α15, α5/α6, and multiple HPV infections with increasing age. The five most common types were HPV52, 18, 53, 58 and 70, while HPV16, 31, 33 ranked 21st, 25th, and 16th, respectively, in the merged cohort with normal cytology (n=14 724). HPV16, 31, and 33 were significantly associated with abnormal cytology, which could have resulted in their rarity in the total merged cohort (n=15 040).

scholarly journals Association of serum and mucosal neutralizing antibodies to human papillomavirus type 16 (HPV-16) with HPV-16 infection and cervical disease

2008 ◽  
Vol 89 (4) ◽  
pp. 910-914 ◽  
Author(s):  
Zizipho Z. A. Mbulawa ◽  
Anna-Lise Williamson ◽  
Debbie Stewart ◽  
Jo-Ann S. Passmore ◽  
Lynette Denny ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Neutralizing Antibodies ◽  
Antibody Responses ◽  
Normal Cytology ◽  
Hpv 16 ◽  
Human Papillomavirus Type 16 ◽  
Immunodeficiency Virus ◽  
Cervical Disease ◽  
Hpv Types

We investigated neutralizing antibodies to human papillomavirus type 16 (HPV-16) in serum and cervical washes from 84 women with normal cytology or cervical disease. Serum neutralizing antibodies were detected in 78 % of women infected at the cervix with HPV-16, compared with 35 % (P=0.002) of women infected with HPV-16-related types (α9 HPV types), 14 % (P<0.0001) of women infected with HPV-16 non-related types and none of HPV-uninfected women. A significant correlation between HPV-16 infection and serum HPV-16-neutralizing antibodies was observed (r s=0.97; P=0.032). Cervical neutralizing antibodies were detected in 38 % of women with HPV-16 infection and in 17 % of women infected with the HPV-16-related type HPV-31. Cervical neutralizing antibodies correlated with HPV-16 infection (r s=0.95; P=0.08), but not with cervical disease. Serum and cervical HPV-16 antibody responses were not affected significantly by human immunodeficiency virus type 1 infection. In conclusion, serum and cervical HPV-16-neutralizing antibodies were found to correlate with HPV-16 infection, but not with cervical disease.

scholarly journals Human papillomavirus type-specific risk of cervical cancer in a population with high human immunodeficiency virus prevalence: case–control study

2011 ◽  
Vol 92 (12) ◽  
pp. 2784-2791 ◽  
Author(s):  
Pontus Naucler ◽  
Flora Mabota da Costa ◽  
Joao Leopoldo da Costa ◽  
Otto Ljungberg ◽  
Antonio Bugalho ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Human Immunodeficiency Virus ◽  
Human Papillomavirus ◽  
Effect Modification ◽  
Hiv Positive ◽  
Hpv 16 ◽  
Cervical Cancer Risk ◽  
Hiv Positive Women ◽  
Immunodeficiency Virus ◽  
Hiv Negative

There are limited data on human papillomavirus (HPV) type-specific cervical cancer risk among human immunodeficiency virus (HIV)-positive women. Previous studies have suggested that HPV 16 would be relatively less important as a causative agent among HIV-positive compared with HIV-negative women. This study investigates HPV type-specific cervical cancer risk in a population in which HIV is endemic. At the Central Hospital, Maputo, Mozambique, 221 cervical cancer cases and 203 hospital-based controls were consecutively enrolled. HPV typing from cervical samples, HIV testing and recording of socio-demographic factors were performed. Logistic regression modelling was used to assess HPV type-specific risk and effect modification between HIV and HPV infection. Infection with HPV 16, 18 and ‘high-risk non-HPV 16/18 types’ (HPV 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59) was associated with cervical cancer in both crude and adjusted analyses. HPV 16 and 18 were the most common types detected in cancer biopsies among both HIV-negative and HIV-positive women. There was no significant evidence of effect modification between any HPV type and HIV infection, and there were no significant differences in the HPV type-specific prevalence when cervical cancers among HIV-positive and HIV-negative women were compared. Within the limitations of the study, the relative importance of different HPV types in cervical carcinogenesis appears not to be modified greatly by HIV infection, suggesting that HPV vaccines might not need to be type-specifically modified to be suitable for populations where HIV is endemic.

Human Papillomavirus Co-Testing Results Effectively Triage Normal Cervical Cytology in HIV-Positive Women Aged 30 Years and Older

2017 ◽  
Vol 21 (2) ◽  
pp. 125-128 ◽  
Author(s):  
Rachel O. Alade ◽  
Olivera Vragovic ◽  
Conor Duffy ◽  
Howard J. Cabral ◽  
Elizabeth A. Stier
Keyword(s):  
Human Papillomavirus ◽  
Cervical Cytology ◽  
Hiv Positive ◽  
Hiv Positive Women ◽  
Normal Cervical Cytology

Human Papillomavirus Types 2, 27, and 57 Identified in Plantar Verrucae from HIV-Positive and HIV-Negative Individuals

2014 ◽  
Vol 104 (2) ◽  
pp. 141-146 ◽  
Author(s):  
Christy M. King ◽  
James S. Johnston ◽  
Kene Ofili ◽  
Maylynn Tam ◽  
Joel Palefsky ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Hiv Positive ◽  
Hpv Typing ◽  
Predominant Type ◽  
Immunodeficiency Virus ◽  
Study Population ◽  
Hpv Types ◽  
Polymerase Chain ◽  
Insight Into ◽  
Hiv Negative

Background Although an increased prevalence of plantar verrucae has been associated with human immunodeficiency virus (HIV) infection, human papillomavirus (HPV) typing studies have not been published about this patient population. We sought to determine the prevalence of HPV types in plantar verrucae of HIV-positive (HIV+) and HIV-negative (HIV–) individuals. Methods Thirty-nine plantar verruca lesions in 17 individuals were examined. Nine participants were HIV+ and eight were HIV–. Detection of HPV was performed by polymerase chain reaction using two sets of primers: MY09/MY11. The type of HPV was determined by hybridization to 38 different HPV types. Clinical types of verrucae were correlated to the HPV strain identified in each lesion. Results Of the 39 plantar verruca samples, 38 typed to HPV-2, HPV-27, and HPV-57 strains in HIV+ and HIV– individuals. Specifically, a large proportion of the samples from HIV– individuals typed as HPV-27 (87.5%), and HPV-2 was the predominant type identified in HIV+ individuals (50%). No rare or atypical HPV types were found in either group. We identified HPV-2 and HPV-27 in 96% of verruca plantaris clinical type. Mosaic warts typed to HPV-27 and HPV-57, and 80% of punctate verrucae typed to HPV-57. Conclusions This study presents an increased prevalence of HPV-2, HPV-27, and HPV-57 in plantar verrucae in this study population and provides insight into the occurrence of these types in HIV+ and HIV– individuals.

scholarly journals Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women

2008 ◽  
Vol 89 (6) ◽  
pp. 1380-1389 ◽  
Author(s):  
Maria Lina Tornesello ◽  
Maria Luisa Duraturo ◽  
Paolo Giorgi-Rossi ◽  
Matilde Sansone ◽  
Roberto Piccoli ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Human Papillomavirus ◽  
High Risk ◽  
Hiv Positive ◽  
Sequencing Analysis ◽  
Hiv Positive Women ◽  
Immunodeficiency Virus ◽  
Hpv Genotypes ◽  
Italian Women ◽  
Hiv Negative

Human immunodeficiency virus (HIV)-positive women have high rates of cervical squamous intraepithelial lesions (SIL) and concurrent human papillomavirus (HPV) infections with a variety of genotypes whose oncogenic risk is poorly documented. The prevalence and persistence of HPV genotypes and HPV16 variants were analysed in 112 HIV-positive and 115 HIV-negative Italian women. HIV-positive women were more likely than HIV-negative women to be infected by HPV at the initial examination (39.3 vs 13.9 %, P<0.001) and to have a higher period prevalence of HPV infection over a 3-year follow-up (43.8 % vs 17.4 %, P<0.001), regardless of CD4+ cell counts and anti-retroviral therapy. ‘High-risk’ and ‘probable high-risk’ HPVs (types 16, 18, 31, 33, 35, 45, 52, 58 and 66), among the 20 different viral genotypes identified, were predominant in HIV-positive (33.9 %) compared with HIV-negative (13.9 %) women. Among HIV-infected women, with normal cytology as well as with SIL of any grade, the most common genotypes were HPV16 followed by HPV81, -58, -72, -33 and -62. HPV16 isolates from 18 HIV-positive and eight HIV-negative women were classified into variant lineages based on sequencing analysis of E6 and E7 genes and the long control region. Whilst the HPV16 G350 European variant was prevalent in both HIV-positive (10.7 %) and -negative women (3.5 %), HPV16 African 2 variant was only detected in HIV-positive women (3.6 %), suggesting different sexual mixing behaviours. The increased prevalence of uncommon viral genotypes and HPV16 variants in HIV-positive Italian women underscores the need to target a wide range of HPV types in cervical screening of high-risk women.

Sign in / Sign up

Export Citation Format

Share Document